Loading provider…
Loading provider…
Allergy & Immunology Physician in San Antonio, TX
NPI: 1063512713Primary Practice Location
Certified Allergy & Asthma of San Antonio, PA
8285 Fredericksburg Rd, San Antonio, TX
Primary Employer
Certified Allergy & Asthma of San Antonio, PA
sanantonioallergist.com
HQ Phone
Get M.D. Robert's Phone Numberphone_androidMobile
Get M.D. Robert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2005 - 2025

American Board of Allergy and Immunology
Allergy & Immunology
University of Texas Medical Branch Hospitals
Fellowship • Allergy and Immunology
2007 - 2009
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Residency • Internal Medicine
2003 - 2006
University of Puerto Rico, Medical Sciences Campus
md.rcm.upr.edu
Medical School
Until 2003
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 235 | 359 |
| 2 | 95165Preparation and provision of single or multiple antigens for allergen immunotherapy | 136 | 5,395 |
| 3 | 95117Injection of incremental dosages of allergen, 2 or more injections | 106 | 1,459 |
| 4 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 53 | 63 |
| 5 | 95115Injection of incremental dosages of allergen | 52 | 683 |
Eosinophilic esophagitis treated with immunotherapy to dust mites.
Role of astrocytes and chemokine systems in acute TNFα induced demyelinating syndrome: CCR2-dependent signals promote astrocyte activation and survival via NF-κB and Akt
Authors: Robert Reddick, Lisa Adams, Marlon Quinones, Seema Ahuja
Publication Date: 2008-01
Lead Sponsor: Sanofi
Collaborators: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Dupilumab